A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study. (2014)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/1745-6215-15-122
PubMed Identifier: 24726032
Publication URI: http://europepmc.org/abstract/MED/24726032
Type: Journal Article/Review
Volume: 15
Parent Publication: Trials
ISSN: 1745-6215